Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,323,021
+$766,133 QoQ
Shares Held
194,643
-0.8% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#76
of 245 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SummitTX Capital, L.P. holds $220,272,212 across 62 Biotechnology names. DYN ranks #20 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
126,401 | $14,034,303 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
374,270 | $12,496,875 | |
| 3 | CYTK |
Cytokinetics Inc
|
112,893 | $9,617,354 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
254,959 | $9,487,024 | |
| 5 | QTTB |
Q32 Bio Inc.
|
733,774 | $9,348,280 | |
| 6 | GMAB |
Genmab A/S
|
318,408 | $8,746,667 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
36,276 | $8,741,427 | |
| 8 | ABVX |
Abivax S.A.
|
65,216 | $8,690,684 |
All Filings in DYN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,323,021 | 194,643 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,556,888 | 196,188 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,758,478 | 243,276 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,681,185 | 132,900 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,132,508 | 118,961 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,358,314 | 129,858 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||